Tablet In Pharma
- All
- News
-
Pharma Firm Lupin Gets US Regulator Nod For Generic Drug To Treat Cancer
- Monday August 29, 2022
- India News | Press Trust of India
Lupin on Monday said it has received a tentative approval from the US health regulator to market Dasatinib tablets, used to treat certain types of cancer, in America.
-
www.ndtv.com
-
Sun Pharma Company Launches COVID-19 Drug Favipiravir In India
- Tuesday August 4, 2020
- India News | ANI
Sun Pharmaceutical Industries has said it has launched Favipiravir (200 mg) in India under the brand FluGuard at an economical price of Rs 35 per tablet for the treatment of mild to moderate cases of COVID-19.
-
www.ndtv.com
-
Indian-American's Pharma Firm Donates 3.4 Million Hydroxychloroquine Tablets
- Wednesday April 8, 2020
- Indians Abroad | Press Trust of India
An Indian American-owned pharma firm has pledged to donate 3.4 million Hydroxychloroquine Sulphate tablets to some of the key COVID-19 battleground states, including New York and Louisiana, joining the war against the dreaded coronavirus which by Tuesday had taken lives of more than 12,800 people in the US alone.
-
www.ndtv.com
-
Pharma Firm Lupin Gets US Regulator Nod For Generic Drug To Treat Cancer
- Monday August 29, 2022
- India News | Press Trust of India
Lupin on Monday said it has received a tentative approval from the US health regulator to market Dasatinib tablets, used to treat certain types of cancer, in America.
-
www.ndtv.com
-
Sun Pharma Company Launches COVID-19 Drug Favipiravir In India
- Tuesday August 4, 2020
- India News | ANI
Sun Pharmaceutical Industries has said it has launched Favipiravir (200 mg) in India under the brand FluGuard at an economical price of Rs 35 per tablet for the treatment of mild to moderate cases of COVID-19.
-
www.ndtv.com
-
Indian-American's Pharma Firm Donates 3.4 Million Hydroxychloroquine Tablets
- Wednesday April 8, 2020
- Indians Abroad | Press Trust of India
An Indian American-owned pharma firm has pledged to donate 3.4 million Hydroxychloroquine Sulphate tablets to some of the key COVID-19 battleground states, including New York and Louisiana, joining the war against the dreaded coronavirus which by Tuesday had taken lives of more than 12,800 people in the US alone.
-
www.ndtv.com